Sarepta Therapeutics, Inc. Equity-NMS: SRPT

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$58.61
Open :$59.22
Today's high :$59.45
Today's low :$54.26
52W low :$54.26
52W high :$173.25
EPS(TTM): :2.34
Shares O/S :97.03 M
Market cap :5.28 B

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Sarepta Therapeutics, Inc. $54.43 -3.04% 25.05 5.28B

Frequently Asked Questions

What is the share price of Sarepta Therapeutics, Inc. today?

Sarepta Therapeutics, Inc. (SRPT) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on helping patients through the discovery and development of ribonucleic acid (RNA)-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. It has developed multiple approved products for the treatment of Duchenne muscular dystrophy (Duchenne) and is developing potential therapeutic candidates for a range of diseases and disorders, including Duchenne, Limb-girdle muscular dystrophies (LGMDs) and other neuromuscular and central nervous system (CNS) related disorders. The Company has developed and commercialized four approved products for the treatment of Duchenne: EXONDYS 51 (eteplirsen), Injection (EXONDYS 51), VYONDYS 53 (golodirsen) Injection (VYONDYS 53), AMONDYS 45 (casimersen) Injection (AMONDYS 45), and ELEVIDYS. Its pipeline includes over 40 programs at various stages of discovery, pre-clinical and clinical development.